Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730002 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
A NA study of Neuropsychiatric Systemic Lupus Erythematosus, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT00730002: Completed NA study of Neuropsychiatric Systemic Lupus Erythematosus, sponsored by University of Michigan.
NCT00730002 is a NA study of Neuropsychiatric Systemic Lupus Erythematosus that has completed, run by University of Michigan. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00730002, a NA study of Neuropsychiatric Systemic Lupus Erythematosus, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if three functional Magnetic Resonance brain imaging techniques: Magnetic Resonance Spectroscopy(MRS),Magnetic Resonance perfusion, and Diffusion Tensor Imaging(DTI) can detect brain alterations distinctive for neuropsychiatric systemic lupus erythematosus (NPSLE)and systemic lupus erythematosus(SLE).
Conditions Studied
Interventions
- PROCEDURE Magnetic resonance imaging
- PROCEDURE Magnetic Resonance Angiography (MRA)
- PROCEDURE MRA
- PROCEDURE diffusion Imaging
Study Locations (1)
Michigan
- University of Michigan Health Systems - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2008-03 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT00730002 record still lists
NCT00730002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Neuropsychiatric Systemic Lupus Erythematosus appearing as the primary indexed condition, and to 4 interventions - of which Magnetic resonance imaging is the first listed.
NCT00730002 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00730002 about?
NCT00730002 is a clinical study titled "Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus". The purpose of this study is to determine if three functional Magnetic Resonance brain imaging techniques: Magnetic Resonance Spectroscopy(MRS),Magnetic Resonance perfusion, and Diffusion Tensor Imaging(DTI) can detect brain alterations distinctive for neuropsychiatric systemic lupus erythematosus (...
What is the current status of trial NCT00730002?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2008-03. Estimated completion is 2014-12.
What conditions does trial NCT00730002 study?
This clinical trial studies the following conditions: Neuropsychiatric Systemic Lupus Erythematosus.
What interventions are being tested in trial NCT00730002?
The interventions under investigation include: Magnetic resonance imaging (PROCEDURE), Magnetic Resonance Angiography (MRA) (PROCEDURE), MRA (PROCEDURE), diffusion Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00730002?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00730002 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropsychiatric Systemic Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00730002's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia